Grants per year
Personal profile
Research Interests
Interested in stem cell/bone marrow transplantation for malignant and non-malignant disorders, and patient outcomes after these transplants. Interested in cancer health disparities specifically in hematologic disorders. Interested in global health with improvement in outcomes for hematologic and oncologic conditions in all regions.
Training Experience
| 2009 | Residency, SUNY/State University of New York Downstate Medical Center |
| 2013 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
| 2014 | Fellowship, University of Texas/MD Anderson Cancer Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MS, Clinical Investigation, Northwestern University
… → 2013
MS, Medicine, Northwestern University
… → 2013
MBBS, Medicine, University of Lagos
… → 2003
Medicine, MD, University of Lagos
… → 2003
Research interests keywords
- Blood Cancer (leukemia and lymphomas)
- Global Health
- Health Disparities
- Hematology
- Oncology
- Transplantation
Fingerprint
Dive into the research topics where Kehinde Adekola is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BMT CTN 1704 - Composite Health Risk Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplant (CHARM)
National Marrow Donor Program, National Heart, Lung, and Blood Institute
8/20/19 → 8/20/23
Project: Research project
-
Prot #KD025-213: Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study)
Medpace Clinical Research LLC, Kadmon Corporation, LLC
5/16/19 → 5/16/22
Project: Research project
-
Prot #JZP963-201: A Phase 2, Prospective, Randomized, Open-label Study on the Efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the Prevention of Acute Graft-versus-Host-Disease in Adult and Pediatric Patients After Allogeneic Hemato
PPD Investigator Services, LLC, Jazz Pharmaceuticals, Inc.
2/20/19 → 2/20/22
Project: Research project
-
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML
Sorror, M. L., Gooley, T. A., Storer, B. E., Gerds, A. T., Sekeres, M. A., Medeiros, B. C., Wang, E. S., Shami, P. J., Adekola, K., Luger, S., Baer, M. R., Rizzieri, D. A., Wildes, T. M., Koprivnikar, J., Smith, J., Garrison, M., Kojouri, K., Schuler, T. A., Leisenring, W. M., Onstad, L. E., & 6 others, Jan 19 2023, In: Blood. 141, 3, p. 295-308 14 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Evaluating Socioeconomic, Racial, and Ethnic Disparities in Survival Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplants
Garcia, L., Feinglass, J., Marfatia, H., Adekola, K. & Moreira, J., 2023, (Accepted/In press) In: Journal of Racial and Ethnic Health Disparities.Research output: Contribution to journal › Article › peer-review
-
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L. D., Baljevic, M., Campagnaro, E., Castillo, J. J., Costello, C., D’Angelo, C., Devarakonda, S., Elsedawy, N., Garfall, A., Godby, K., Hillengass, J., Holmberg, L., Htut, M., Huff, C. A., Hultcrantz, M., Kang, Y., Larson, S., & 9 others, Jan 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 1, p. 67-81 15 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Examining the Efficacy of Bright Light Therapy on Cognitive Function in Hematopoietic Stem Cell Transplant Survivors
Wu, L. M., Valdimarsdottir, H. B., Amidi, A., Reid, K. J., Ancoli-Israel, S., Bovbjerg, K., Fox, R. S., Walker, L., Matharu, A., Kaseda, E. T., Galvin, J. P., Adekola, K., Winkel, G., Penedo, F. & Redd, W. H., Oct 2022, In: Journal of biological rhythms. 37, 5, p. 471-483 13 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Multiple Myeloma, Version 3.2022: Featured Updates to the NCCN Guidelines
Callander, N. S., Baljevic, M., Adekola, K., Anderson, L. D., Campagnaro, E., Castillo, J. J., Costello, C., Devarakonda, S., Elsedawy, N., Faiman, M., Garfall, A., Godby, K., Hillengass, J., Holmberg, L., Htut, M., Huff, C. A., Hultcrantz, M., Kang, Y., Larson, S., Liedtke, M., & 9 others, Jan 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 1, p. 8-19 12 p.Research output: Contribution to journal › Article › peer-review
41 Scopus citations
Datasets
-
Examining the Efficacy of Bright Light Therapy on Cognitive Function in Hematopoietic Stem Cell Transplant Survivors
Wu, L. M. (Creator), Valdimarsdottir, H. B. (Creator), Amidi, A. (Creator), Reid, K. J. (Creator), Ancoli-Israel, S. (Creator), Bovbjerg, K. (Creator), Fox, R. S. (Creator), Walker, L. (Creator), Matharu, A. (Creator), Kaseda, E. T. (Creator), Galvin, J. P. (Creator), Adekola, K. (Creator), Winkel, G. (Creator), Penedo, F. (Creator), Redd, W. H. (Creator) & Ancoli-Israel, S. (Creator), SAGE Journals, 2022
DOI: 10.25384/sage.c.6124612.v1, https://sage.figshare.com/collections/Examining_the_Efficacy_of_Bright_Light_Therapy_on_Cognitive_Function_in_Hematopoietic_Stem_Cell_Transplant_Survivors/6124612/1
Dataset